Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamideReport as inadecuate




Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide - Download this document for free, or read online. Document in PDF available to download.

Journal of Infection and Chemotherapy

, Volume 18, Issue 5, pp 753–755

First Online: 28 December 2011Received: 15 September 2011Accepted: 16 November 2011

Abstract

Although many treatments have been applied to treat hormone-refractory prostate cancer HRPC, therapeutic outcome is not altogether satisfactory. In the case of locally recurring HRPC, uncontrolled gross hematuria, dysuria, and scalding are often experienced. We report a patient who improved following intra-arterial infusion of cisplatin CDDP and ifosfamide IFM to treat urinary retention caused by locally recurring HRPC. After chemotherapy, cancer volume was remarkably reduced and symptoms improved.

KeywordsHormone-refractory prostate cancer Intra-arterial infusion chemotherapy Urinary retention  Download fulltext PDF



Author: Keiichiro Uemura - Kiyoaki Nishihara - Tokumasa Hayashi - Katsuro Tomiyasu - Kei Matsuoka

Source: https://link.springer.com/







Related documents